Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 May 23;19(3):547–555. doi: 10.1016/j.cgh.2020.05.038

Table 4:

Suggested age of last screening episode for colorectal cancer based on the number needed to screen to gain one life year, by sex, comorbidity status and prior screening with biennial faecal immunochemical testing or colonoscopy. The faecal immunochemical test had a positivity of 7.5% (23 μg Hb/g faeces).

Screening Historya / Comorbidity statusb Females Males
No Low Mod Sev No Low Mod Sev
Perfect Prior Screening with FIT 78 72 72 66 76 76 72 66
Most Prior Screening with FIT 84 82 78 70 80 80 76 70
Reasonable Prior Screening with FIT 86 84 82 76 82 82 78 74
Some Prior Screening with FIT 88 86 86 80 84 84 82 78
No Prior Screening 90 90 90 86 88 88 86 82
Colonoscopy 10 years prior 74 68 66 <66 73 72 69 <66
Colonoscopy 15 years prior 83 76 74 68 80 78 75 66

Abbreviations: FIT = faecal immunochemical test; Mod = moderate; Sev = severe

Key: Blue – stop screening later than recommended in guidelines; Green – stop screening in line with guidelines; Red – stop screening earlier than recommended in guidelines

a.

Detailed descriptions of screening history are found in Table 1. In brief, perfect prior screening assumes 100% attendance in prior screening rounds, most prior screening assumes 75% attendance in prior screening rounds, reasonable prior screening assumes 50% attendance in prior screening rounds, some prior screening assumes 25% attendance in prior screening rounds and no prior screening assumes no attendance in prior screening rounds. For colonoscopy we assume screening occurred 10 and 15 years prior to the investigated stop-age.

b.

Detailed descriptions of comorbid conditions are found in Table 2. In brief there are four categories: no comorbidity, low comorbidity, moderate comorbidity and severe comorbidity